Kratom-based products have exploded in popularity in recent years despite a lack of FDA approval. Did a Myrtle Beach supplier ...

Ever since the U.S. Drug Enforcement Administration (DEA) tried in 2016 to classify kratom as a dangerous Schedule 1 drug, states have been on their own.

A House subcommittee will hold a hearing today covering safety lapses and improvements to be made to the organ donor system. In other news: the FDA's debate on antidepressant use during pregnancy; the ...

Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access ...

Quarterly net revenues of $159 million, up 6% year-over-year, with 4,331 active patients on therapy as of June 30, 2025 Results from Phase 3 PANOVA-3 clinical trial presented at 2025 ASCO Annual ...

Excedrin Migraine is easily accessible and does work for many, but it may not be wise to rely on it for treating frequent migraine attacks.

With a hot and dry summer in the forecast, officials say wildfires are expected to expand in Western Canada and parts of the north.